Potential drug-drug interactions in the outpatient setting.

作者: Jennifer Elston Lafata , Lonni Schultz , Jan Simpkins , K Arnold Chan , John R. Horn

DOI: 10.1097/01.MLR.0000215807.91798.25

关键词:

摘要: Background: Although medication safety research has tended to focus on inpatients, the of drug use among outpatients is also a concern. Objective: We estimate frequency potentially interacting concomitant dispensing outpatients. Research Design: report number and percent patients annually dispensed an object interest (ie, warfarin, digoxin, cyclosporine, or lovastatin/simvastatin) with random sample insured adults receiving care from 10 integrated delivery systems. 2 definitions dispensing: medications dispensed: 1) during time period for which patient had other available (‘days supply') 2) same day. U.S. population codispensed these pairs. Results: Among interest, between 17.8% (95% confidence interval [CI] = 17.1–18.6%) 28.0% CI 24.0–32.1%) were concomitantly using “days supply” definition, 7.1% 6.6–7.7%) 17.7% 14.4–21.1%) “same day” definition. Extrapolating population, 1.29 1.25–1.33; day) 2.67 2.62–2.72; days supply) million are 1 4 Conclusions: found evidence An opportunity exists better understand how such translates into adverse events ultimately improved safety.

参考文章(46)
Gunter Mj, Young Lr, Hurley Js, Frost Fj, Nelson Ww, Roberts Mh, Solberg Li, Crain Al, Measuring patient safety in ambulatory care: potential for identifying medical group drug-drug interaction rates using claims data. The American Journal of Managed Care. ,vol. 10, pp. 753- 759 ,(2004)
Rachel Czubak, Jasmine Tucker, Barbara J Zarowitz, Optimizing Drug Prescribing in Managed Care Populations Disease Management & Health Outcomes. ,vol. 12, pp. 147- 167 ,(2004) , 10.2165/00115677-200412030-00002
H Xu, A Rashkow, Clarithromycin-induced digoxin toxicity: a case report and a review of the literature. Connecticut medicine. ,vol. 65, pp. 527- 529 ,(2001)
Elizabeth E Roughead, Andrew L Gilbert, Lloyd N Sansom, John G Primrose, Drug‐related hospital admissions: a review of Australian studies published 1988‐1996 The Medical Journal of Australia. ,vol. 168, pp. 405- 408 ,(1998) , 10.5694/J.1326-5377.1998.TB138996.X
Chunliu Zhan, Rosaly Correa-de-Araujo, Arlene S. Bierman, Judy Sangl, Marlene R. Miller, Stephen W. Wickizer, Daniel Stryer, Suboptimal prescribing in elderly outpatients: potentially harmful drug-drug and drug-disease combinations. Journal of the American Geriatrics Society. ,vol. 53, pp. 262- 267 ,(2005) , 10.1111/J.1532-5415.2005.53112.X
Jens Rengelshausen, Christoph Göggelmann, Jürgen Burhenne, Klaus-Dieter Riedel, Jochen Ludwig, Johanna Weiss, Gerd Mikus, Ingeborg Walter-Sack, Walter E. Haefeli, Contribution of increased oral bioavailability and reduced nonglomerular renal clearance of digoxin to the digoxin-clarithromycin interaction. British Journal of Clinical Pharmacology. ,vol. 56, pp. 32- 38 ,(2003) , 10.1046/J.1365-2125.2003.01824.X
K.N. Van Dijk, R.B.J. Brouwers, K. Ter Huurne, P.B. van den Berg, L.T.W. de Jong‐van den Berg, C.S. de Vries, Prescribing of gastroprotective drugs among elderly NSAID users in the Netherlands Pharmacy World & Science. ,vol. 24, pp. 100- 103 ,(2002) , 10.1023/A:1016133400222
Peter McManus, Andrea Mant, Philip Mitchell, Don Birkett, John Dudley, Co-prescribing of SSRIs and TCAs in Australia: how often does it occur and who is doing it? British Journal of Clinical Pharmacology. ,vol. 51, pp. 93- 98 ,(2001) , 10.1046/J.1365-2125.2001.01319.X
Robert Barrons, Evaluation of personal digital assistant software for drug interactions. American Journal of Health-system Pharmacy. ,vol. 61, pp. 380- 385 ,(2004) , 10.1093/AJHP/61.4.380
Brian J Lipworth, Thomas M MacDonald, J L Hayes, Josie Evans, Potentially hazardous co-prescribing of beta-adrenoceptor antagonists and agonists in the community. British Journal of General Practice. ,vol. 46, pp. 423- 425 ,(1996)